SkyQuest Technology Group has recently published a comprehensive Genetic Testing Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The genetic testing market has progressed substantially over the past years owing to major improvements in technologies, growing healthcare needs, and increased awareness. The market is majorly impacted by growing awareness and demand and improvements in technologies. There is a rising public awareness and growing interest in genetic testing, propelled by media coverage and educational campaigns for different health conditions common across the globe.
Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).
Moreover, advancements in sequencing technologies like NGS (Next-Generation Sequencing) have notably improved genetic testing in terms of speed, accuracy, and cost-effectiveness. Nonetheless, the genetic testing market is hampered by ethical and privacy issues. There are several issues regarding potential misuse of genetic information and data privacy. Concerns like handling sensitive genetic information or genetic discrimination by insurance companies or workers are a few legal and ethical challenges. Still, expanding applications of genetic testing and improvement in genomics are posing opportunities for the growth of the genetic testing market.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/genetic-testing-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Genetic Testing Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region.
Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR – based Testing, FISH and Others.
Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness – Predisposition/ Risk / Tendency.
Based on Product, the market is segmented into Consumables, Equipment and Software & Services.
Based on Channel, the market is segmented into Online and Offline.
Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Genetic Testing Market – Regional Analysis:
Geographically, North America is dominating the genetic testing market owing to various reasons including economic, technological and societal factors. The leading nations in the region like Canada, the United States, brag about well-established healthcare infrastructure with modernized facilities, clinical laboratories, and research institutes.
Asia-Pacific is expected to be the fastest-growing region among others owing to several factors that impact the region’s unique economic, demographic, and healthcare dynamics. Rising health awareness and an ever-growing population are propelling the market in the region. Asia-Pacific is home to a speedily and large growing population. Growing emphasis on preventive healthcare and rising health awareness propel the demand for these services as people are seeking early diagnostics and personalized health services.
Top Market Players in Genetic Testing Market are:
Illumina, Inc. (USA)
Roche Holding AG (Switzerland)
Thermo Fisher Scientific Inc. (USA)
QIAGEN N.V. (Netherlands)
Abbott Laboratories (USA)
Agilent Technologies, Inc. (USA)
Bio-Rad Laboratories, Inc. (USA)
Danaher Corporation (USA)
Myriad Genetics, Inc. (USA)
23andMe, Inc. (USA)
Invitae Corporation (USA)
Natera, Inc. (USA)
NeoGenomics, Inc. (USA)
Guardant Health, Inc. (USA)
Siemens Healthineers AG (Germany)
Hologic, Inc. (USA)
BGI Genomics Co., Ltd. (China)
Eurofins Scientific (Luxembourg)
Adaptive Biotechnologies Corporation (USA)
Recent Developments:
In June 2024, Deep Genomics, a techbio company based in Toronto, recently unveiled its new laboratory and office in Cambridge, Massachusetts. This new office and lab will be an expansion of its office in Toronto and multiple leadership hires. They will work to create RNA therapies for genetic illnesses with ML.
In July 2023, Quest Diagnostics, a diagnostic information services leader, introduced its 1st consumer-initiated genetic test, named Genetic Insights. The novel offering helps individuals understand possible risk of suffering from specific inheritable health disease with improved technology and end-to-end assistance comprising personalized health access and report to genetic counselling.
In May 2024, Ambry Genetics and PacBio declared that they are chosen by GREGoR and UCI to assist the Pediatric (MGRC) Mendelian Genomics Research Center program for better interpreting the primary biology of rare illnesses.
You may Also Like
https://issuu.com/skyquest-technology/docs/landfill_gas_market_projected_to_rise_as_renewable
https://issuu.com/skyquest-technology/docs/oligonucleotide_synthesis_market_to_receive_overwh
Forward-Looking Insights
The Genetic Testing Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
